Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.

Pan, Hung-Wei; Su, Hsing-Hao; Hsu, Chao-Wen; Huang, Guan-Jin; Wu, Tony Tong-Lin

Pan, Hung-Wei; Su, Hsing-Hao; Hsu, Chao-Wen; Huang, Guan-Jin; Wu, Tony Tong-Lin.

Afiliação

Pan HW; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung.
Su HH; Department of Applied Chemistry, National Pingtung University, Pingtung.
Hsu CW; Department of Otorhinolaryngology-Head and Neck Surgery.
Huang GJ; Department of Pharmacy and Graduate Institute of Pharmaceutical Technology, Tajen University, Pingtung.
Wu TT; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung.

Onco Targets Ther ; 10: 3531-3543, 2017.

Article em En | MEDLINE | ID: mdl-28761362

Palavras-chave

TPX2; micronucleation; prostate cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Onco Targets Ther Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google